DANIEL PECHSTEDT: Open Payments
NPI 1831597756 · TORRANCE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 7 payments from 5 companies in 2025. Trend: 2023 $141 · 2024 $85 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $43 |
| Intra-Sana Laboratories | 2 | $33 |
| Phadia US Inc. | 1 | $30 |
| PFIZER INC. | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
Products named: RELTONE 200 MG, ImmunoCAP, PREVNAR 20, REPATHA, SHINGRIX, OTEZLA.
Industry payments across CA — which companies pay providers there.
